Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Pozycja w akcjach #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Cena akcji
$0.6
Ostatnia synchronizacja: 2024-08-14
Kapitalizacja rynkowa
$2.09M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategoria

Zyski dla ASLAN Pharmaceuticals Limited (ASLN)
Zyski w Mar 2024 TTM: $-34.90M
Według najnowszych raportów finansowych ASLAN Pharmaceuticals Limited, obecny zysk firmy wynosi $-34.90M. W roku 2022 firma osiągnęła zysk w wysokości $-51.28M, spadek w porównaniu do zysku z roku 2021, który wynosił $-31.59M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy ASLAN Pharmaceuticals Limited od 2014 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$5.27B -15,214.03%
US
$1.95B -5,689.14%
NL
- -
CH
- -
KR
$3.01B -8,712.20%
BE